MN1 and astrocytoma (excluding glioblastoma): In astrocytoma and other nervous system tumors, MN1 gene rearrangements (such as MN1-BEND2 and MN1-CXXC5) drive tumor occurrence via activating the PDGFRα signaling pathway (69).